Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lam Research Corporation (LRCX) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Lam Research CorporationTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Lam Research Corporation vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Lam Research Corporation trades at $279.68 (market cap $359.06B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: Lam Research Corporation is far larger — about 33.8× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays the higher dividend (0.65%). Which is the better fit depends on your goals — on Pluang, investors hold Lam Research Corporation for 61 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

LRCXRDY
Market Cap
$359.06B$10.61B
Volume
10,336,2943,738,869
Sector
TechnologyHealth
52-Week High
$433.33$15.38
52-Week Low
$139.59$11.38
Typical Hold Time
61 Days0 Days
Enterprise Value
$357.21B$10.51B
Dividend Yield
0.46%0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lam Research Corporation

Lam Research (LRCX) trades at $301.11, down 2.73% on the day, amid a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $18.44B in 2025, with a net income margin of 31.27% and robust cash flow from operations of $6.17B. Analyst sentiment remains overwhelmingly positive, with a consensus price target of $375.68.

LRCX presents a compelling long-term opportunity driven by AI-driven semiconductor equipment demand, though near-term technical weakness and high valuation multiples pose risks. The company's strategic positioning in advanced chip manufacturing supports growth, but investors should monitor execution against earnings expectations and competitive dynamics in the semiconductor equipment sector.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LRCX
80% Buy20% Sell
Avg holding period · 61 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Lam Research Corporation

Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.

Read more on LRCX →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →